Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sales Agreement between Mike Wang and Dr. William Fang for the marketing and sales of Dr. Fang’s early detection system of Cardio Vascular diseases. The device provides unique 3D imaging for the Cardio Vascular conditions for patients and has already won approval of US FDA. It has very positive significance in helping preventing heart attacks, which are the number one killer in the US as well as in the world.
Pro Health Inc., a Tennessee company organized in 2016. It entered into a Sales Agreement with Provision Healthcare , LLC, a Tennessee limited liability company, in the selling of ProNova Equipment, which is a Proton Treatment device used in the treatment of cancer. Other than the sale of equipment, Pro Health will also be providing Total Solution Services related with the use of the Equipment.
Sales Partner PROVISION HEALTHCARE received $185,000,000 from Government/Investors to Build 2 CANCER CLINICS
Why Buy? The DD is Solid and Undiscovered >>>
Audited Financials Soon
New Management Team/Board
Nasdaq's $AMPH V.P. joined Board
No Dilution/Convertible Debt
CEO Stock Purchase Agreement $765,000.00 @ $0.012 PPS
7-15M FLOAT
Sales Agreements for FDA APPROVED Cardiovascular Devices & Cancer Equipment
How short is NITE, I love it.
Nasdaq's Amphistar Pharmaceutical $18+ V.P. joined AAGH! Market Cap $1 Billion
I expect the CEO will cancel a huge portion of the OS or his holdings later on down the road. Remains to be seen..
if the market cap is already $327M, no way this could go 60x from 0.015 to $1. That would be like an $18 Billion market cap.....what am I missing here
Prior to the Shell Buyout there were 20b OS, so yes, the new CEO holds over 80% plus other Insiders hold 10%.
.0177 up, Break .03 and she flies, mark it!
Good to hear, spread the word...many don't realize what's here.
I got in yesterday at .015 !! Nice finding Cheeky !!
Nasdaq's AMPHISTAR's V.P. on Board, $500,000,000 Company!!
I'm in for 25K shares for now. Thanks for all the work you put in helping uncover hidden gems like this. Just wish I'd seen it (and jumped on board) at the half cent range. LOL
Long Term, $1.00+, these guys are Loaded and BIGTIME!!
Huge Board Member from NASDAQ's AMPH....Mr. Chan served as Managing Director at Evidia Biosciences, a clinical laboratory and pathology service provider consists of 3 labs servicing over 700 physicians in Southern California and Pennsylvania; Vice President at Amphastar Pharmaceutical, (NASDAQ:AMPH); and Director of International Society of Pharmaceutical Engineers (ISPE, 18,000 members in 90 countries worldwide) LA. Ch. Mr. Chan started his investment banking career back in 1990 as Operation Manager of Tse's Investment Ltd., the investment division of TSL, Ltd. (0417.HK), running stock and forex investment floor with 6 trading offices throughout HK
HUGE FUTURE, FDA APPROVED CARDIO VASCULAR DETECTION/PRONOVA EQUIPMENT for CANCER TREATMENT >> The Company under the new management will focus its business in the health related industry. The Company’s Chairman and president, Mike Wang, is the owner of several health related businesses below with which The Company is evaluating the possibilities of forming several joint ventures. The Company might effectuate the joint ventures using stocks.
1. Health & Beauty Group Inc. It is a California company in the business of R &D and sale of vitamins and nutritional supplements. It owns more than 20 formulas and engages contract manufacturers to make these products. The company has built up solid sales records both in the US as well as in China.
2. Pro Health Inc., a Tennessee company organized in 2016. It entered into a Sales Agreement with Provision Healthcare , LLC, a Tennessee limited liability company, in the selling of ProNova Equipment, which is a Proton Treatment device used in the treatment of cancer. Other than the sale of equipment, Pro Health will also be providing Total Solution Services related with the use of the Equipment. FDA Approved, Cleared 510(k)
3. Sales Agreement between Mike Wang and Dr. William Fang for the marketing and sales of Dr. Fang’s early detection system of Cardio Vascular diseases. The device provides unique 3D imaging for the Cardio Vascular conditions for patients and has already won approval of US FDA. It has very positive significance in helping preventing heart attacks, which are the number one killer in the US as well as in the world.
Float between 7-15m, NO Dilution or Notes!
CEO/Insiders Hold 80-90% of O/S, plus Purchased 63m more @ $0.012!!
AAGH is a NEW COMPANY, NEW MANAGEMENT....
Effective June 22, 2017, the Board of Directors (the "Board") of America Great Health (the "Company") determined that it was in the best interest of the Company to separate the role of President from the role of Chief Executive Officer ("CEO"). Accordingly, the Board approved the appointment of Herric Chan as the Company's CEO replacing Mike Q. Wang.
Mr. Chan, age 46, has 20 years extensive business experiences across investment banking, lending, real estate, sales & marketing, biotech, healthcare, and pharmaceutical industry. He currently serves as Director of Alliance Capital Group (Hong Kong) servicing the IPO, financial advisory, and asset management in Hong Kong and China markets; Associate Partner of Chimera Co. Ltd. (Thailand), a financial advisory and asset management firm servicing South East Asia and Taiwan markets; and CEO of Round Table Group, (California, CalBRE #02022089) a licensed brokerage firm in the US specializes in multinational M&A and commercial real estate markets..
Prior to current positions, Mr. Chan served as Managing Director at Evidia Biosciences, a clinical laboratory and pathology service provider consists of 3 labs servicing over 700 physicians in Southern California and Pennsylvania; Vice President at Amphastar Pharmaceutical, (NASDAQ:AMPH); and Director of International Society of Pharmaceutical Engineers (ISPE, 18,000 members in 90 countries worldwide) LA. Ch. Mr. Chan started his investment banking career back in 1990 as Operation Manager of Tse's Investment Ltd., the investment division of TSL, Ltd. (0417.HK), running stock and forex investment floor with 6 trading offices throughout HK.
On January 29, 2018, we engaged Sadler, Gibb & Associates, LLC ( “ Sadler Gibb ” ) as our independent registered public accounting firm to audit the Company ’ s consolidated financial statements as of June 30, 2018 and for the year then ended. Sadler Gibb will be performing reviews of the unaudited consolidated quarterly financial statements to be included in the Company ’ s quarterly reports on Form 10-Q for the year ended June 30, 2018 as well as going forward.
During each of the Company ’ s two most recent fiscal years and through the date of this report, (a) the Company has not engaged Sadler Gibb as either the principal accountant to audit the Company ’ s financial statements, or as an independent accountant to audit a significant subsidiary of the Company and on whom the principal accountant is expected to express reliance in its report; and (b) the Company or someone on its behalf did not consult Sadler Gibb with respect to (i) either: the application of accounting principles to a specified transaction, either completed or proposed; or the type of audit opinion that might be rendered on the Company ’ s financial statements, or (ii) any other matter that was either the subject of a disagreement or a reportable event as set forth in Items 304(a)(1)(iv) and (v) of Regulation S-K.
Item 1.01 Entry Into a Material Definitive Agreement.
On January 04, 2018, America Great Health (the “Company”) entered into a Stock Purchase Agreement (the “Stock Purchase Agreement”) with Health & Beauty Group, Inc. (the “Seller”), a California Corporation focus on manufacuring and distrubution of health supplements and costmetic beauty proucts. Pursuant to the Stock Purchase Agreement, the Company agreed to purchase 51% of common shares of the Seller, for an aggregate purchase price of $765,000, which consisting of 63,750,000 outstanding shares of the Company’s common stock at $0.012 per share.
The foregoing description of the Stock Purchase Agreement and its terms is qualified in its entirety by the full text of the agreement, which is filed as Exhibit 10.1 to, and incorporated by reference in, this report.
Effective January 02, 2018, the Board of Directors (the "Board") of America Great Health (the "Company") determined that it was in the best interest of the Company to hire a new Chief Operating Officer ("COO"). Accordingly, the Board approved the appointment of Andy Weichu Sheng as the Company's COO.
Mr. Sheng, age 62, has 30 years extensive experiences in business management and operation. Prior to current positions, Mr. Sheng served as President at Tradeshowusa.com since 2002; and Chief Executive Officer at Bizusa.us since 2013, Mr. Sheng served as President at Shoes Expert; during 1998 to 2002, Mr. Sheng served as President and Chief Executive Officer at Hemei Security; Mr. Sheng also served as President at SICO Group General Electric China Sole Distributor for three years since 1990.
You have to read the filings or Intro board, new growing company which many people haven't grasped yet.
Ok, I have start doing some homework on this company after you point out GLFH to me. Looks a this may be a great price point to jump onboard.
240k at .016 bid. Wonder how long it’ll last
So now csti wants to be the dbag today too funny
Few dumb market orders will do that - trades extremely thin
I agree, someone wanted out this morning at any price, we will go up from here.
It's Bigger than we know....Pro Health Inc., a Tennessee company organized in 2016. It entered into a Sales Agreement with Provision Healthcare , LLC, a Tennessee limited liability company, in the selling of ProNova Equipment , which is a Proton Treatment device used in the treatment of cancer. Other than the sale of equipment, Pro Health will also be providing Total Solution Services related with the use of the Equipment.
2016/12/08/provision-healthcare-receives-fda-clearance-of-the-pronova-sc360-proton-therapy-system-2/
http://provisionhealthcare.com/proton-therapy/proton-therapy-system/
$AAGH Partner Provision Healthcare building 2 Clinincs $185,000,000....Provident plans $85 million proton therapy center in Baton Rouge
Advocate staff report MAY 10, 2017 - 9:45 AM (1)
FacebookTwitterEmailPrintSave
An $85 million proton radiation cancer treatment center will be built in Baton Rouge by Provident ProtonCare, a division of Provident Resources Group in Baton Rouge.
The Louisiana ProtonCare Center, projected to open near the end of 2019, will be located near the junction of Interstates 10 and 12, and will be the latest addition to the Baton Rouge Health District. The center's proton therapy will use a targeted, high-energy dose of radiation to destroy tumor cells. Proton therapy is used in situations where treatment options are limited for eye and brain, head and neck, prostate, liver, lung, breast and pediatric cancers, as well as on tumors that are close to vital organs or tissue that could be damaged by traditional radiation treatments.
Clinical partners in the center's operation are Mary Bird Perkins Cancer Center, Our Lady of the Lake Regional Medical Center, Baton Rouge General and Woman’s Hospital. They will serve as a regional network giving patient's access to the center in cases in which proton therapy treatment is an option.
Story Continued Below
The project was announced Wednesday by Provident Resources Group Chairman and CEO Steve Hicks and Gov. John Bel Edwards.
The center is the second one in the area to be announced within the past three weeks. Construction on the $100 million Louisiana Proton Therapy Center is slated to begin this year at the University Medical Center campus in New Orleans by Tennessee-based Provision Healthcare. Construction is expected to begin by late this year and last about two years.
$100 million cancer treatment center planned on University Medical Center campus by Provision Healthcare
The two proposed south Louisiana centers will join two dozen such facilities in operation in the U.S., the next closest ones being in Shreveport and Houston. Another dozen are either under construction or in development, according to the National Association for Proton Therapy's website.
The Baton Rouge center will create 95 jobs, with with an average salary of $105,000, plus benefits. Louisiana Economic Development estimates the project will result in another 101 indirect jobs.
Provident ProtonCare will receive an incentive package from the state that includes a $1 million performance-based grant, payable in five annual installments beginning in 2021. Provident also can access the state's workforce training program and is expected to use Louisiana’s Quality Jobs Program, which provides a cash rebate of up to 6 percent of a company's annual payroll for as long as a decade.
The New Orleans center is receiving the same package and is expected to pursue federal New Markets Tax Credits in its financing. It is expected to create 60 new jobs, paying an average salary of $100,000, plus benefits.
Other organizations involved in landing the capital city's center are the Baton Rouge Area Foundation and Baton Rouge Area Chamber.
Provident will finance, own and operate the nonprofit therapy center through a special purpose entity, Hicks said. After 20 years, Provident will donate the facility to the Baton Rouge Area Foundation as a permanent asset in the Baton Rouge Health District.
Hicks said Provident will issue tax-exempt and taxable bonds to finance the center. The medical centers will form a joint venture to handle clinical operations and patient treatment.
Hicks said donation of the center to BRAF after the facility is paid off is a way of supporting the community Provident is based in. “We’re not doing this in any other market, but Baton Rouge is our home town,” he said.
“We’re excited to add this new cancer-treatment technology that will allow our citizens to receive care in the Baton Rouge Health District rather than going out of state,” said Executive Vice President John Spain of the Baton Rouge Area Foundation.
Provident ProtonCare is venturing into proton therapy centers, with a facility under construction in Atlanta, where Provident is entering into a clinical agreement with Emory University’s Winship Cancer Institute.
Baton Rouge placed high on Provident’s priority list for new investments, in part because of the collaboration of health care and economic development partners in Louisiana, Hicks said.
Provident has assembled a national team for the development of its proton therapy centers, with expertise in the construction, design and financing of facilities. The project team includes Gilbane Development Co., Stantec Architects and Citigroup Global Markets. Provident’s long-term partner Ion Beam Applications SA will provide proton therapy technology, the Proteus Plus system, for the ProtonCare Center.
Construction of the center will begin in 2018. Hiring for the 95 positions will begin in 2019, with full employment expected by 2021. Final negotiations for the center’s property location in the Baton Rouge Health District are underway and nearing a conclusion.
“Louisiana’s most valuable asset is her people, and their health is of great importance to us. With that in mind, it is crucial that the best treatments are available to them,” Edwards said.
“This center will not only provide optimum care and hope for patients, but it will be a great asset to the economic development of the capital city,” said Baton Rouge Mayor-President Sharon Weston Broome.
Roughly 1.7 million new cases of cancer were diagnosed in the U.S. last year, and the majority of patients were treated with radiation therapy. Interest in proton therapy has risen since the Food and Drug Administration approved it in 2001, but some medical experts have questioned its results for treating some cancers.
Unlike X-rays, which can transfer energy to healthy tissues between a tumor and the body's surface, proton beams can hit a target while sparing healthy tissues from the treatment's side effects, according to the National Cancer Institute.
Founded in 1999, Provident Resources Group is a national nonprofit involved in the creation, ownership and operation of education, health care, senior living and multifamily housing facilities and services
Financials are Due this month, should be interesting to see what's in store. $AAGH
Intro Board Updated...$AAGH
Approx. 25k to .03, Green close coming. $AAGH
My bets $AAGH is a multi dollar stock long term.
Break .03 and buyers will swarm...no shares available.
Trying to shack out cheap stock, no trades offered 0.013, backto 0.02. Typical move. When they let go, it wii pop
AUDITED FINANCIALS Coming....Engagement of New Independent Registered Public Accounting Firm.
On January 29, 2018, we engaged Sadler, Gibb & Associates, LLC ( “ Sadler Gibb ” ) as our independent registered public accounting firm to audit the Company ’ s consolidated financial statements as of June 30, 2018 and for the year then ended. Sadler Gibb will be performing reviews of the unaudited consolidated quarterly financial statements to be included in the Company ’ s quarterly reports on Form 10-Q for the year ended June 30, 2018 as well as going forward.
During each of the Company ’ s two most recent fiscal years and through the date of this report, (a) the Company has not engaged Sadler Gibb as either the principal accountant to audit the Company ’ s financial statements, or as an independent accountant to audit a significant subsidiary of the Company and on whom the principal accountant is expected to express reliance in its report; and (b) the Company or someone on its behalf did not consult Sadler Gibb with respect to (i) either: the application of accounting principles to a specified transaction, either completed or proposed; or the type of audit opinion that might be rendered on the Company ’ s financial statements, or (ii) any other matter that was either the subject of a disagreement or a reportable event as set forth in Items 304(a)(1)(iv) and (v) of Regulation S-K.
Float is Approximately 7-15m, trades a lot tighter.
Absolutely No Dilution, No Noteholders..In fact INSIDER'S are Buying and Locking the Whole OS!
Yahoo is fairly accurate, placing $52m Enterprise Value, trading @ $0.01-.02 is preposterous!
Easily worth 10-20x
My Goal is $0.10+
New Manangement/Board >>
Mr. Mike Q. Wang Interim CEO, Interim Pres, VP, CFO, Sec. & Director 62
Mr. Herric Chan Independent Advisor 46
Mr. Tony Wu VP of Operation and Member of Board of Advisors 37
Robert Chen Ph.D., MHA Director of Bus. Devel. and Member of Board of Advisors
Mr. Terry Lee MBA Managing Director and Member of Board of Advisors 65
Once investors and bidders realize the value, and the lack of sellers, they'll move up...Green close today imo.
Followers
|
52
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1937
|
Created
|
10/09/12
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |